Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Lacutamab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS
    Innate Pharma’s Lacutamab Gets FDA Breakthrough Therapy For SS

    17 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250216384344/en

    BUSINESSWIRE
    17 Feb 2025
    Share Share
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides
    Innate Pharma: Positive Phase 2 Lacutamab Data In Mycosis Fungoides

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603023665/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program
    Innate Pharma Announces U.S. FDA Lifts Partial Hold on Lacutamab Program

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240103221044/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab
    Innate Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab

    10 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231209939521/en

    BUSINESSWIRE
    10 Dec 2023
    Share Share
    Innate Pharma Announces Presentation of Interim Results of Ph 2 TELLOMAK Study
    Innate Pharma Announces Presentation of Interim Results of Ph 2 TELLOMAK Study

    22 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230921031989/en

    BUSINESSWIRE
    22 Sep 2023
    Share Share
    Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab
    Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab

    12 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230611748794/en

    BUSINESSWIRE
    12 Jun 2023
    Share Share